Decision aid for advanced cancer patients considering more treatment
Part of Cancer clinical trials.
This study is testing a tool called TA-DA to help patients with advanced cancer and their caregivers make decisions about further treatment after at least two prior therapies. It aims to improve shared decision-making.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have advanced cancer that has spread or cannot be cured
- You have had at least 2 previous treatments to control the cancer
- You are able to make your own treatment decisions
- You speak English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling program called Focused ACT (FACT) to help patients with advanced cancer cope with stress and death anxiety. It involves talking with a counselor about important areas of your life.
This study tests a program to help family caregivers talk about death with their loved one who has advanced cancer. It may help caregivers feel more prepared and supported.
This study tests whether telemedicine (video or phone calls) can help people with advanced cancer and their caregivers. You and a family member or friend will join telemedicine sessions to get support and manage your needs.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This study looks at ways to help people with advanced cancer or aggressive lymphoma make better treatment decisions with their doctors. If you qualify, you'll be asked to read a short story about a patient in a similar situation and answer questions about your thoughts on care options.
This study tests a decision aid to help men aged 65 and older with early-stage prostate cancer decide whether to choose active surveillance (monitoring the cancer instead of immediate treatment). The goal is to see if the tool helps men and their care partners make a more informed choice.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.